[6-K] Check Point Software Technologies Ltd Current Report (Foreign Issuer)
On 28 Jul 2025, TSSP Sub-Fund HoldCo, LLC and its managing member Alan Waxman jointly filed a Schedule 13G disclosing passive ownership in Caris Life Sciences, Inc. ("CAI") as of 30 Jun 2025.
- TSSP Sub-Fund HoldCo: 23,166,128 shares (8.3 % of the 277,932,779 outstanding).
- Alan Waxman: deemed beneficial owner of 24,385,399 shares (8.8 %) through control of HoldCo and related Sixth Street vehicles.
- Shares are distributed across five entities including Barnett Equity Holdings, Sixth Street Specialty Lending Inc. and related investment LLCs.
Both filers report zero sole and shared voting/dispositive power over the respective share counts; ownership is reported under Rule 13d-1(c) as a passive investment. No additional transactions, changes in control, or certifications were disclosed.
Il 28 luglio 2025, TSSP Sub-Fund HoldCo, LLC e il suo membro gestore Alan Waxman hanno presentato congiuntamente un Schedule 13G, rivelando una partecipazione passiva in Caris Life Sciences, Inc. ("CAI") al 30 giugno 2025.
- TSSP Sub-Fund HoldCo: 23.166.128 azioni (8,3% delle 277.932.779 azioni in circolazione).
- Alan Waxman: considerato beneficiario effettivo di 24.385.399 azioni (8,8%) tramite il controllo di HoldCo e dei veicoli correlati di Sixth Street.
- Le azioni sono distribuite tra cinque entità, tra cui Barnett Equity Holdings, Sixth Street Specialty Lending Inc. e LLC di investimento correlate.
Entrambi i soggetti segnalano zero poteri di voto o dispositivi esclusivi e condivisi sulle rispettive quantità di azioni; la proprietà è dichiarata ai sensi della Regola 13d-1(c) come investimento passivo. Non sono state comunicate ulteriori transazioni, cambiamenti di controllo o certificazioni.
El 28 de julio de 2025, TSSP Sub-Fund HoldCo, LLC y su miembro administrador Alan Waxman presentaron conjuntamente un Schedule 13G revelando una participación pasiva en Caris Life Sciences, Inc. ("CAI") al 30 de junio de 2025.
- TSSP Sub-Fund HoldCo: 23,166,128 acciones (8.3% de las 277,932,779 en circulación).
- Alan Waxman: considerado beneficiario efectivo de 24,385,399 acciones (8.8%) a través del control de HoldCo y los vehículos relacionados de Sixth Street.
- Las acciones están distribuidas entre cinco entidades, incluyendo Barnett Equity Holdings, Sixth Street Specialty Lending Inc. y LLCs de inversión relacionadas.
Ambos declaran cero poder exclusivo y compartido de voto o disposición sobre las cantidades respectivas de acciones; la propiedad se reporta bajo la Regla 13d-1(c) como una inversión pasiva. No se divulgaron transacciones adicionales, cambios de control o certificaciones.
2025년 7월 28일, TSSP Sub-Fund HoldCo, LLC와 그 관리 멤버인 Alan Waxman은 2025년 6월 30일 기준 Caris Life Sciences, Inc.("CAI")에 대한 수동적 소유권을 공개하는 Schedule 13G를 공동 제출했습니다.
- TSSP Sub-Fund HoldCo: 23,166,128주 (총 277,932,779주 중 8.3%).
- Alan Waxman: HoldCo 및 관련 Sixth Street 차량의 통제를 통해 24,385,399주(8.8%)의 실질적 소유자로 간주됩니다.
- 주식은 Barnett Equity Holdings, Sixth Street Specialty Lending Inc. 및 관련 투자 LLC를 포함한 다섯 개 법인에 분산되어 있습니다.
양측 모두 해당 주식 수에 대해 단독 및 공동 의결권/처분권이 전혀 없음을 보고하였으며, 소유권은 규칙 13d-1(c)에 따라 수동적 투자로 보고됩니다. 추가 거래, 지배권 변경 또는 인증 사항은 공개되지 않았습니다.
Le 28 juillet 2025, TSSP Sub-Fund HoldCo, LLC et son membre gestionnaire Alan Waxman ont conjointement déposé un Schedule 13G révélant une détention passive dans Caris Life Sciences, Inc. ("CAI") au 30 juin 2025.
- TSSP Sub-Fund HoldCo : 23 166 128 actions (8,3 % des 277 932 779 en circulation).
- Alan Waxman : considéré comme bénéficiaire effectif de 24 385 399 actions (8,8 %) via le contrôle de HoldCo et des véhicules affiliés de Sixth Street.
- Les actions sont réparties entre cinq entités, dont Barnett Equity Holdings, Sixth Street Specialty Lending Inc. et des LLC d’investissement associées.
Les deux déclarants rapportent aucun pouvoir de vote ou de disposition exclusif ou partagé sur les nombres d’actions respectifs ; la propriété est déclarée selon la règle 13d-1(c) en tant qu’investissement passif. Aucune transaction supplémentaire, changement de contrôle ou certification n’a été divulgué.
Am 28. Juli 2025 reichten TSSP Sub-Fund HoldCo, LLC und dessen geschäftsführendes Mitglied Alan Waxman gemeinsam einen Schedule 13G ein, in dem sie passiven Besitz an Caris Life Sciences, Inc. ("CAI") zum 30. Juni 2025 offenlegten.
- TSSP Sub-Fund HoldCo: 23.166.128 Aktien (8,3 % von insgesamt 277.932.779 ausstehenden Aktien).
- Alan Waxman: gilt als wirtschaftlich Berechtigter von 24.385.399 Aktien (8,8 %) durch Kontrolle von HoldCo und zugehörigen Sixth Street Vehikeln.
- Die Aktien sind auf fünf Einheiten verteilt, darunter Barnett Equity Holdings, Sixth Street Specialty Lending Inc. und verbundene Investment-LLCs.
Beide Melder geben keine alleinigen und keine gemeinsamen Stimm- oder Verfügungsrechte über die jeweiligen Aktienbestände an; der Besitz wird gemäß Regel 13d-1(c) als passives Investment gemeldet. Es wurden keine zusätzlichen Transaktionen, Kontrollwechsel oder Zertifizierungen offengelegt.
- Sixth Street-affiliated investors now hold an 8.8 % passive stake in CAI, adding a prominent institutional backer to the shareholder base.
- None.
Insights
TL;DR: Sixth Street affiliates reveal ~9 % passive stake in CAI; material for ownership mix but no control intent signaled.
The Schedule 13G indicates that Sixth Street–managed entities, via TSSP Sub-Fund HoldCo, accumulated 23.2 m CAI shares, while managing member Alan Waxman is deemed to control 24.4 m shares. At 8.3-8.8 % of outstanding stock, this represents a significant minority holding that must be reported but remains below activism thresholds. Because the filing is on Form 13G (not 13D), it signals no current intent to influence management, suggesting a passive, possibly credit-linked or crossover equity position typical of Sixth Street. From a valuation standpoint, new institutional support can tighten the float and may improve liquidity. However, absent any transactional detail or future plans, the disclosure is largely informational; fundamental outlook for CAI is unchanged.
Il 28 luglio 2025, TSSP Sub-Fund HoldCo, LLC e il suo membro gestore Alan Waxman hanno presentato congiuntamente un Schedule 13G, rivelando una partecipazione passiva in Caris Life Sciences, Inc. ("CAI") al 30 giugno 2025.
- TSSP Sub-Fund HoldCo: 23.166.128 azioni (8,3% delle 277.932.779 azioni in circolazione).
- Alan Waxman: considerato beneficiario effettivo di 24.385.399 azioni (8,8%) tramite il controllo di HoldCo e dei veicoli correlati di Sixth Street.
- Le azioni sono distribuite tra cinque entità, tra cui Barnett Equity Holdings, Sixth Street Specialty Lending Inc. e LLC di investimento correlate.
Entrambi i soggetti segnalano zero poteri di voto o dispositivi esclusivi e condivisi sulle rispettive quantità di azioni; la proprietà è dichiarata ai sensi della Regola 13d-1(c) come investimento passivo. Non sono state comunicate ulteriori transazioni, cambiamenti di controllo o certificazioni.
El 28 de julio de 2025, TSSP Sub-Fund HoldCo, LLC y su miembro administrador Alan Waxman presentaron conjuntamente un Schedule 13G revelando una participación pasiva en Caris Life Sciences, Inc. ("CAI") al 30 de junio de 2025.
- TSSP Sub-Fund HoldCo: 23,166,128 acciones (8.3% de las 277,932,779 en circulación).
- Alan Waxman: considerado beneficiario efectivo de 24,385,399 acciones (8.8%) a través del control de HoldCo y los vehículos relacionados de Sixth Street.
- Las acciones están distribuidas entre cinco entidades, incluyendo Barnett Equity Holdings, Sixth Street Specialty Lending Inc. y LLCs de inversión relacionadas.
Ambos declaran cero poder exclusivo y compartido de voto o disposición sobre las cantidades respectivas de acciones; la propiedad se reporta bajo la Regla 13d-1(c) como una inversión pasiva. No se divulgaron transacciones adicionales, cambios de control o certificaciones.
2025년 7월 28일, TSSP Sub-Fund HoldCo, LLC와 그 관리 멤버인 Alan Waxman은 2025년 6월 30일 기준 Caris Life Sciences, Inc.("CAI")에 대한 수동적 소유권을 공개하는 Schedule 13G를 공동 제출했습니다.
- TSSP Sub-Fund HoldCo: 23,166,128주 (총 277,932,779주 중 8.3%).
- Alan Waxman: HoldCo 및 관련 Sixth Street 차량의 통제를 통해 24,385,399주(8.8%)의 실질적 소유자로 간주됩니다.
- 주식은 Barnett Equity Holdings, Sixth Street Specialty Lending Inc. 및 관련 투자 LLC를 포함한 다섯 개 법인에 분산되어 있습니다.
양측 모두 해당 주식 수에 대해 단독 및 공동 의결권/처분권이 전혀 없음을 보고하였으며, 소유권은 규칙 13d-1(c)에 따라 수동적 투자로 보고됩니다. 추가 거래, 지배권 변경 또는 인증 사항은 공개되지 않았습니다.
Le 28 juillet 2025, TSSP Sub-Fund HoldCo, LLC et son membre gestionnaire Alan Waxman ont conjointement déposé un Schedule 13G révélant une détention passive dans Caris Life Sciences, Inc. ("CAI") au 30 juin 2025.
- TSSP Sub-Fund HoldCo : 23 166 128 actions (8,3 % des 277 932 779 en circulation).
- Alan Waxman : considéré comme bénéficiaire effectif de 24 385 399 actions (8,8 %) via le contrôle de HoldCo et des véhicules affiliés de Sixth Street.
- Les actions sont réparties entre cinq entités, dont Barnett Equity Holdings, Sixth Street Specialty Lending Inc. et des LLC d’investissement associées.
Les deux déclarants rapportent aucun pouvoir de vote ou de disposition exclusif ou partagé sur les nombres d’actions respectifs ; la propriété est déclarée selon la règle 13d-1(c) en tant qu’investissement passif. Aucune transaction supplémentaire, changement de contrôle ou certification n’a été divulgué.
Am 28. Juli 2025 reichten TSSP Sub-Fund HoldCo, LLC und dessen geschäftsführendes Mitglied Alan Waxman gemeinsam einen Schedule 13G ein, in dem sie passiven Besitz an Caris Life Sciences, Inc. ("CAI") zum 30. Juni 2025 offenlegten.
- TSSP Sub-Fund HoldCo: 23.166.128 Aktien (8,3 % von insgesamt 277.932.779 ausstehenden Aktien).
- Alan Waxman: gilt als wirtschaftlich Berechtigter von 24.385.399 Aktien (8,8 %) durch Kontrolle von HoldCo und zugehörigen Sixth Street Vehikeln.
- Die Aktien sind auf fünf Einheiten verteilt, darunter Barnett Equity Holdings, Sixth Street Specialty Lending Inc. und verbundene Investment-LLCs.
Beide Melder geben keine alleinigen und keine gemeinsamen Stimm- oder Verfügungsrechte über die jeweiligen Aktienbestände an; der Besitz wird gemäß Regel 13d-1(c) als passives Investment gemeldet. Es wurden keine zusätzlichen Transaktionen, Kontrollwechsel oder Zertifizierungen offengelegt.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
|
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
(1) |
to reelect six current non-outside directors;
|
(2) |
to ratify the appointment and compensation of Kost, Forer, Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accounting firm for the fiscal year ending December 31, 2025, and for such
additional period until the next annual general meeting of shareholders – Israeli law requires that we ask you, on an annual basis, to approve our auditors; when this proposal is raised, you will also be invited to discuss our 2024
consolidated financial statements;
|
(3) |
as required by Israeli law, to approve the compensation for our Chief Executive Officer;
|
(4) |
as required by Israeli law, to approve the compensation for the Executive Chair of our Board of Directors;
|
(5) |
as required by Israeli law, to readopt our Executive Compensation Policy; and
|
(6) |
to amend our Employee Stock Purchase Plan (ESPP).
|
Name
|
Number of shares beneficially owned (1)
|
% of class of shares (2)
|
Number of options/RSUs/PSUs (3)
|
Exercise prices of options
|
Dates of expiration of options
|
Gil Shwed (4)
|
27,753,225
|
25.2%
|
2,880,000
|
$114.23 - $173.21
|
6/18/2026 – 10/30/2031
|
All directors and officers as a group (13 persons including Mr. Shwed)(4)
|
28,149,958
|
25.5%
|
3,225,227
|
$114.23 - $216.86
|
6/18/2026 – 2/11/2032
|
(1) |
The number of ordinary shares shown includes shares that each shareholder has the right to acquire pursuant to stock options that are presently exercisable or exercisable within 60 days after July 23, 2025, and restricted share units and
performance share units that vest within 60 days after July 23, 2025.
|
(2) |
If a shareholder has the right to acquire shares by exercising stock options or the vesting of restricted share units or performance share units, these shares are deemed outstanding for the purpose of computing the percentage owned by
the specific shareholder (that is, they are included in both the numerator and the denominator) but they are disregarded for the purpose of computing the percentage owned by any other shareholder.
|
(3) |
Number of shares subject to stock options that were immediately exercisable or are exercisable within 60 days from July 23, 2025, and restricted share units and performance share units that vest within 60 days after July 23, 2025.
|
(4) |
The address for Mr. Shwed is c/o Check Point Software Technologies Ltd., 5 Shlomo Kaplan Street, Tel Aviv 6789159, Israel. Except as may be provided by applicable community property laws, Mr. Shwed has sole voting and investment power
with respect to his ordinary shares. The share amount and holding percentage include unexercised stock options. Without such unexercised stock options, the 24,873,225 issued ordinary shares held by Gil Shwed represented 23.2% of the
outstanding ordinary shares and voting rights as of July 23, 2025.
|
Year ended December 31, 2024
|
||||||||
Audit fees (1)
|
$
|
0.9
|
69
|
%
|
||||
Audit-related fees (2)
|
0.2
|
15
|
%
|
|||||
Tax fees (3)
|
0.2
|
16
|
%
|
|||||
All other fees
|
--
|
--
|
||||||
Total
|
$
|
1.3
|
100
|
%
|
(1) |
“Audit fees” are fees for audit services for 2024, including fees associated with the annual audit (including audit of our internal control over financial reporting) and reviews of our quarterly financial results submitted on
Form 6-K, consultations on various accounting issues and audit services provided in connection with other statutory or regulatory filings.
|
(2) |
“Audit-related fees” are fees for professional services, mainly related to due diligence work.
|
(3) |
“Tax fees” are fees for professional services rendered by our auditors for tax compliance, tax planning and tax advice on actual or contemplated transactions, tax consulting associated with international transfer prices and employee
benefits.
|
• |
ensure that the interests of the executives are closely aligned with the interests of Check Point’s shareholders and oriented towards long-term value creation;
|
• |
emphasize equity compensation and long-term incentives so that executives have an interest in Check Point’s sustained growth and success;
|
• |
motivate the executives to achieve results with integrity and fairness;
|
• |
support a performance culture that is based on merit, and differentiates and rewards excellent performance, both in short and long-term, and recognizes Check Point’s company values; and
|
• |
balance cash- and equity-based rewards for short-term and long-term results, with an emphasis on variable, performance-based equity compensation to ensure sustained business performance over time.
|
Atlassian Corp
|
Autodesk Inc.
|
Cadence Design Systems Inc.
|
Cloudflare, Inc.
|
CrowdStrike Holdings, Inc.
|
CyberArk Software Ltd.
|
Datadog, Inc.
|
Dynatrace, Inc.
|
Fortinet Inc.
|
Gen Digital Inc.
|
NICE Ltd.
|
Nutanix, Inc.
|
Okta, Inc.
|
Palo Alto Networks Inc.
|
PTC Inc.
|
Tyler Technologies Inc.
|
VeriSign Inc.
|
Zscaler, Inc.
|
Name
|
Year
|
Annual Salary(4)
|
RSU Awards ($)(5)
|
PSU Awards ($)(5)
|
Option Awards ($)(5)
|
Non-Equity Incentive Plan Compensation (5)
|
All
Other Compensation
|
Total
|
Nadav Zafrir
(CEO)
|
2025 (1)
|
$436,364
|
$5,000,000
|
$4,000,000
|
$6,000,000
|
$454,545
|
$113,703
|
$16,004,612
|
2024 (2)
|
$394,845
|
$4,400,000
|
$4,000,000
|
$6,000,000
|
$411,297
|
$102,885
|
$15,309,027
|
|
Gil Shwed (previous CEO)
|
2024 (3)
|
$18,298
|
-
|
-
|
-
|
-
|
$20,528
|
$38,826
|
2023
|
$18,209
|
-
|
-
|
$22,273,450
|
-
|
$9,427
|
$22,301,087
|
|
2022
|
$18,073
|
-
|
-
|
$18,405,350
|
-
|
$9,528
|
$18,432,951
|
• |
Cash Compensation. The CEO’s cash compensation package is comprised of an annual salary of NIS 1.44 million (~$436,364) and an annual cash target bonus of NIS 1.5 million (~$454,545).
|
o |
The annual cash bonus targets shall be set annually by the Compensation Committee and the Board of Directors in line with Check Point’s Executive Compensation Policy and the performance targets specified in the policy. The maximum bonus
can reach up to 200% of the annual base salary.
|
o |
No change is being proposed to Mr. Zafrir’s cash compensation, as approved by the shareholders in 2024.
|
• |
CEO Equity Grant.
|
o |
In 2024, upon his appointment as CEO, Mr. Zafrir was granted an equity compensation package comprised of (i) an RSU award of $4.4 million to be vested in four annual installments, with $1.4 million vesting after the first year and $1
million vesting in each of the remaining three years, (ii) a PSU award of $4 million subject to achievement of a bookings growth performance criteria set by the Compensation Committee (over a period of four years), and (iii) a stock option
award of $6 million vesting in four annual installments.
|
o |
It is proposed that Mr. Zafrir be granted a CEO Equity Grant with similar components as his 2024 equity compensation package, in substantially the same amount, with an aggregate dollar value increase of $600,000, reflecting a 3.9%
increase to the total CEO compensation package.
|
o |
In making its recommendation, the Compensation Committee noted the fact that Mr. Zafrir’s cash compensation (guaranteed salary or annual cash bonus) will not be increased.
|
◾ |
That, notwithstanding the small increase in the dollar value of the grant, the aggregate number of units (RSUs, PSUs and options) included in the CEO Equity Grant is expected to be less than the aggregate number of units granted to the
CEO in 2024 due to the significant increase to Check Point’s share price since the 2024 grant date.
|
o |
The proposed CEO Equity Grant is comprised of the following elements:
|
◾ |
an RSU award of $5.0 million to be vested in four annual installments, with $2.0 million vesting after the first year and $1.0 million vesting in each of the remaining three year;
|
◾ |
a PSU award of $4.0 million subject to achievement of a bookings and ARR growth performance criteria set by the Compensation Committee (over a period of four years); and
|
◾ |
a stock option award to be vested in four annual installments, with a Black-Scholes-Merton value of $6.0 million calculated on the date of grant.
|
o |
The equity awards will be granted to Mr. Zafrir on the date of the annual general meeting, calculated based on the closing price of Check Point’s ordinary shares on Nasdaq on such date. The exercise price of the stock options will equal
the closing share price on Nasdaq on the date of grant.
|
o |
Special terms: Similar to the 2024 equity grant, in the event Check Point initiates a termination of the CEO’s employment in his first 24 months of employment (other than for cause) (i.e., prior
to December 1, 2026), then 50% of his unvested RSUs and stock options will vest at the end of his employment. In case of death or permanent disability, 100% of the CEO’s unvested equity awards will vest immediately with any applicable
performance conditions deemed to be achieved at target.
|
• |
provide ongoing mentorship and support to the CEO and other senior executives;
|
• |
provide high-level strategic direction and guidance to ensure Check Point’s long-term goals align with its mission and vision;
|
• |
support Check Point’s technology and R&D activities;
|
• |
provide oversight over the development and construction of the new Check Point campus and other Check Point operations;
|
• |
counsel across a wide range of issues facing the business, including corporate strategy, strategic customer and partner relationships, corporate development, market landscape, growth opportunities, and industry developments;
|
• |
support the hiring and retention of key executives, and play a key role in identifying and developing future leaders within the organization to ensure continuity;
|
• |
represent the Company at major industry events, conferences, and public speaking engagements to enhance Check Point’s profile and reputation;
|
• |
be available to shareholders and other key stakeholders for consultation and direct communication, and engage with them on key matters;
|
• |
chair meetings of the Board and facilitate discussions to ensure effective decision-making and governance;
|
• |
meet regularly with the Lead Independent Director and act as a liaison between the Board and management, ensuring clear communication and alignment;
|
• |
preside over annual and special meetings of shareholders;
|
• |
consult with the Nominating, Sustainability and Corporate Governance Committee on candidates for nomination or appointment to the Board and ensure that appropriate committee structure and composition is in place to effectively implement
corporate objectives set out by the Board; and
|
• |
provide additional services required by the Board.
|
- |
Each non-executive director is required to beneficially own Check Point securities (vested and unvested) equal to 5X the annual non-executive director cash retainer.
|
- |
Check Point’s Chief Executive Officer is required to beneficially own Check Point securities equal to $4.5 million.
|
- |
Each Check Point executive officer (other the CEO) identified in Item 6A of Check Point’s Annual Report on Form 20-F is required to beneficially own Check Point securities equal to his or her annual base salary.
|
|
By Order of the Board of Directors.
/S/ GIL SHWED
GIL SHWED Chairman of the Board of Directors
|
• |
ensure that the interests of the Executives are closely aligned with the interests of Check Point’s shareholders and emphasize equity pay and long-term incentives so that Executives have an interest in Check Point’s sustained growth and
success;
|
• |
motivate the Executives to achieve results with integrity and fairness;
|
• |
support a performance culture that is based on merit, and differentiates and rewards excellent performance, both in short and long-term, and recognizes Check Point’s company values; and
|
• |
balance rewards for both short-term and long-term results to ensure sustained business performance over time.
|
• |
the educational, professional experience, skills and accomplishments of the Executive;
|
• |
the Executive’s position, role, scope of responsibilities and prior compensation arrangements;
|
• |
data of peer companies, including companies in the industry and/or geographic market;
|
• |
compensation for comparably situated executives;
|
• |
Check Point’s performance and general market conditions;
|
• |
the Executive’s expected contribution to Check Point’s future growth and profitability;
|
• |
the relation between the average cost of compensation of the Executives and the average and median cost of compensation of Check Point’s employees and contractors, as well as whether such variation has an effect on employment relations;
and
|
• |
any requirements prescribed by applicable law from time to time.
|
• |
financial results;
|
• |
sales results;
|
• |
operating profits;
|
• |
annualized booking;
|
• |
revenue results;
|
• |
efficiency metrics;
|
• |
internal and external customer satisfaction;
|
• |
shareholder value;
|
• |
execution of projects; and
|
• |
attainment to milestones.
|
• |
with respect to the CEO, 0.3% of Check Point’s fair market value (calculated based on the price of Check Point’s ordinary shares on Nasdaq); and
|
• |
with respect to each of the other Executives (other than non-employee directors), 0.15% of Check Point’s fair market value.
|
• |
paid vacation days;
|
• |
paid sick days;
|
• |
recuperation pay according to applicable law;
|
• |
employer contributions to an education fund, and to an insurance policy or a pension fund for severance and pension;
|
• |
employer contribution towards work disability insurance;
|
• |
D&O indemnification, insurance and exculpation to the maximum extent permitted by applicable law, as amended from time to time;
|
- |
Cash Retainer. In accordance with the approval of the Compensation Committee, the Board of Directors and the shareholders, Check Point pays each of its non-employee directors an annual cash
retainer of $40,000 for the services provided to the Board of Directors and an annual cash retainer of $7,500 for each Board committee membership. In addition, Check Point currently pays
|
- |
Equity-Based Incentives. In accordance with the approval of the Compensation Committee, the Board of Directors and the shareholders, non-employee directors receive an
automatic option grant and are also eligible for discretionary awards under the Equity Incentive Plans. Each non-employee director who is first elected or appointed to the Board of Directors is granted an option to purchase 25,000
ordinary shares with an exercise price equal to the fair market value of the ordinary shares on the date of grant (calculated based on the price of Check Point’s ordinary shares on Nasdaq) and restricted share units (RSUs) with a value of
$200,000 on the date of the initial election or appointment, vesting in equal annual installments over a four-year period. On the date of each annual general meeting of shareholders, each non-employee director who is to continue to serve
as a non-employee director after the annual meeting is granted an option to purchase an additional
|
|
|
|
|
|
|
|
Check Point Software Technologies Ltd.
|
|
|
|
/s/ Shira Yashar
|
|||
|
|
|
|
|
|
|
Shira Yashar
|
|
|
|
|
VP, General Counsel
|
|
|
![]() |
|
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
ATTN: LEGAL DEPARTMENT
5 SHLOMO KAPLAN STREET
TEL AVIV 6789159, ISRAEL
|
VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit
your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Daylight Time on September 2, 2025. Have your proxy card in hand when you access the web site and follow the instructions to obtain your
records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail
or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
V77298-P36250 KEEP THIS PORTION FOR YOUR RECORDS
|
DETACH AND RETURN THIS PORTION ONLY
|
The Board of Directors recommends you vote FOR the following proposals:
|
|||||||||||||
1. |
Election of Directors
|
||||||||||||
|
|
|
For
|
Against
|
Abstain
|
|
|
For
|
Against
|
Abstain
|
|
||
|
|
1a. |
Gil Shwed
|
☐ | ☐ | ☐ |
|
2. |
To ratify the appointment and compensation of Kost, Forer, Gabbay & Kasierer, a member of Ernst & Young
Global, as the independent registered public accounting firm for 2025.
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1b. |
Nadav Zafrir
|
☐
|
☐
|
☐
|
|
3. |
To approve the compensation for Check Point’s Chief Executive Officer.
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
1c. |
Tzipi Ozer-Armon
|
☐ |
☐
|
☐ |
|
4. |
To approve the compensation for Check Point’s Executive Chair of the Board.
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
1d. |
Dr. Tal Shavit
|
☐ |
☐
|
☐
|
|
5. |
To readopt Check Point's Executive Compensation Policy.
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
1e. |
Jill D. Smith
|
☐ |
☐
|
☐
|
|
6, |
To amend Check Point's Employee Stock Purchase Plan (ESPP).
|
☐ | ☐ |
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1f. |
Jerry Ungerman
|
☐ |
☐
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Yes | No | ||||||||||||
Please indicate if you plan to attend this meeting.
|
☐ | ☐ | |||||||||||
NOTE: Please sign exactly as your name or names appear(s) on this proxy. When shares are held jointly, each holder should sign. When signing as executor,
administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership,
please sign in partnership name by authorized person.
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date |
Signature (Joint Owners)
|
Date |
![]() ![]() |